In an age when science has conquered many diseases, a centuries-old illness is quietly making its way back into the spotlight. Tuberculosis (TB), once thought to be declining steadily, is now knocking on Central Asia and Europe's doors again and it is knocking hardest on those least prepared to fight it: children.

In 2023, health experts raised the alarm after a disturbing surge in tuberculosis cases among children under 15 years of age in the WHO’s European region. This group made up 4.3% of all new and relapsed TB cases, a ten percent increase from the previous year. What should concern everyone is that this is the third consecutive year TB infections in children have risen in this part of the world.

When children are affected, it signals more than just a health crisis, it points to deep cracks in public health systems, vaccine coverage, early diagnosis, and community-level interventions. Kids aren't just smaller adults. Their symptoms are harder to detect, and delays in treatment can lead to more severe outcomes.

The common assumption that TB is a problem exclusive to poorer nations is no longer valid. Over 172,000 new and relapsed TB cases were reported across 53 countries, including several in central Asia. Of these, close to 37,000 were from the European Union and European Economic Area (EU/EEA) alone, marking a rise of nearly 2,000 cases from 2022.

Infections among children were mirrored across both the broader WHO European region and the EU/EEA countries, reinforcing the idea that no part of Europe is immune. TB is not just persisting, it is evolving, adapting, and targeting new groups.

One of the most alarming aspects of the resurgence is the rise of multidrug-resistant tuberculosis. MDR-TB does not respond to the two most potent TB drugs, making it far more difficult and expensive to treat. As more strains become resistant, treatment regimens grow longer, costlier, and less effective.

This resistance not only hampers recovery for patients but also threatens public health at large. When MDR-TB spreads, it requires an urgent upgrade in both medication protocols and health systems that are already under strain.

Children catching TB suggests that community transmission is widespread and undetected. Unlike adults, kids are less likely to have developed immune protection, and they often contract TB from household contacts. Their infections highlight where prevention efforts are failing.

More worryingly, the symptoms in children often masquerade as common respiratory issues. This means diagnoses are frequently delayed, allowing the bacteria to wreak havoc unchecked. The longer TB goes untreated, the more severe and contagious it becomes.

Global TB control is facing a funding crisis. Even before recent cuts to international development aid, the world was already short $11 billion to effectively tackle the disease. This funding gap threatens to undo years of progress.

Experts like WHO Europe’s regional director, Hans Kluge, emphasize that eradicating TB isn’t an impossible dream, but a conscious choice governments must make. If that choice isn’t made now, the cost of today’s neglect will come due tomorrow with interest.

Pamela Rendi-Wagner, head of the ECDC, urges European nations to place TB back on the public health priority list. The clock is ticking, and delaying action only allows TB to spread further and mutate faster.

The good news? There is hope, and it lies in smarter strategies and wider access.

First, European health bodies stress the need to scale up detection. Earlier diagnosis means earlier treatment, which cuts transmission rates drastically. Newer, shorter, fully oral drug regimens are already showing great results in treating drug-resistant strains and should be made more widely available.

Next, TB testing must be strengthened across all age groups. Clinics, schools, and community centers should be equipped to offer tests easily and without stigma. The earlier a case is identified, the fewer people are exposed.

Third, TB preventive treatments should not be optional especially for those most at risk. These preventive therapies are crucial in keeping TB from taking hold in exposed but not yet infected individuals.

TB is not just a medical issue; it's a social one. It thrives in places where housing is overcrowded, nutrition is poor, healthcare access is limited, and education about the disease is minimal. All these factors are often interconnected, forming a vicious cycle that sustains TB.

To break that cycle, countries need to look beyond hospitals. Community engagement, awareness drives, school education programs, and improved living conditions all form the broader net needed to catch TB before it spreads.

A child diagnosed with TB in 2023 represents a failure of systems. It means missed opportunities for prevention, delayed diagnoses, and insufficient awareness. But each case is also a call to action.

Health agencies, NGOs, and governments must treat this resurgence not as an isolated issue but as a national priority. Children deserve to grow up free from the shadows of such a curable disease. And as a society, we owe it to them to be proactive, not reactive.

The challenge is massive, but so is the opportunity. With global attention and coordinated efforts, TB can be tackled. But it requires bold investments, consistent surveillance, and most importantly, the political will to act.

Tuberculosis has returned to remind us of something critical: that no disease ever really disappears without constant vigilance. And when children start falling prey, it's a red flag no society can afford to ignore.

The question is no longer whether TB can be defeated. The question is whether we are willing to make the choices necessary to defeat it. The lives of thousands of children across Europe hang in the balance. Tomorrow's outcomes depend on today's decisions.

Will we rise to the occasion? Or will we continue to let a curable disease define the fate of our youngest generation?
The answer, as always, lies in our collective will to act now.